reviewImmunological ReviewsJun 15, 2010Closed access

The PD‐1 pathway in tolerance and autoimmunity

Brigham and Women's Hospital · Harvard University

PubMed
Indexed incrossrefpubmed

Abstract

Regulatory T cells (Tregs) and the PD-1: PD-ligand (PD-L) pathway are both critical to terminating immune responses. Elimination of either can result in the breakdown of tolerance and the development of autoimmunity. The PD-1: PD-L pathway can thwart self-reactive T cells and protect against autoimmunity in many ways. In this review, we highlight how PD-1 and its ligands defend against potentially pathogenic self-reactive effector T cells by simultaneously harnessing two mechanisms of peripheral tolerance: (i) the promotion of Treg development and function and (ii) the direct inhibition of potentially pathogenic self-reactive T cells that have escaped into the periphery. Treg cells induced by the PD-1 pathway…

Citation impact

2,280
total citations
FWCI
25.10
Percentile
100%
References
222
Citations per year

Authors

3

Topics & keywords

Keywords
  • Autoimmunity
  • Peripheral tolerance
  • Immunology
  • Immune system
  • Biology
  • Immune tolerance
  • Inflammation
  • Immune privilege
No related works found for this paper.